These final results, along with a preceding report displaying that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 support the concept of focusing on ACKR3 as a novel strategy to modulate the opioid program, which could open new therapeutic avenues for opioid-related Diseases. Identify your assortment: Title https://chanakyax912xph5.prublogger.com/profile